Revolutionizing Breast Cancer Surgery with Advanced Imaging Tech
Transforming Cancer Surgery with Advanced Technology
In a groundbreaking move, CHRISTUS St. Vincent has integrated Perimeter Medical Imaging AI's state-of-the-art S-Series Optical Coherence Tomography (OCT) technology into their surgical practices. This innovative technology allows surgeons to visualize tissue margins more effectively during procedures, significantly enhancing the potential for optimal patient outcomes in breast cancer surgeries.
The Power of Real-Time Imaging
Traditionally, surgeons have relied on X-ray, ultrasound, or MRI technologies in the operating room, which do not provide the necessary detail needed to see disease at the cellular level. Waiting for pathology results can take up to ten days, potentially leading to additional procedures if margins are not clear. The introduction of the S-Series OCT addresses this gap by offering surgeons real-time, high-resolution images that reveal crucial information about tissue conditions.
Improving Outcomes for Patients
Dr. Amani Jambhekar, a surgical breast oncologist at CHRISTUS St. Vincent, emphasizes the significance of this technology in her practice. By enhancing her toolkit with the S-Series OCT, she and her multidisciplinary team can ensure that patients benefit from the most cutting-edge methods available during surgery. This tangible improvement translates to better-informed surgical decisions and enhanced confidence in patient outcomes.
How the S-Series OCT Works
The S-Series OCT utilizes light to produce detailed cross-sectional images of tissue microstructures, achieving ten times more resolution than ultrasound and a staggering hundred times more than MRI. This advanced imaging technology allows surgeons to visualize tissues down to 2 mm, significantly impacting their ability to assess ducts, vessels, and glands in real-time.
CEO's Vision for the Future
Perimeter's CEO, Adrian Mendes, expresses his enthusiasm for the implementation of the S-Series at CHRISTUS St. Vincent. He highlights that this advancement aligns perfectly with the company’s mission: to enhance patient access to transformative imaging technologies that may improve health outcomes and reduce healthcare costs across diverse communities.
The Technology’s Broader Implications
Perimeter Medical Imaging AI is reshaping the surgical landscape with its commitment to innovation in medical technology. The S-Series OCT system is FDA-cleared and provides real-time visualization of excised tissues, permitting surgeons to work with unprecedented clarity. Furthermore, the next-generation Perimeter B-Series OCT equipped with ImgAssist AI is currently undergoing trials, aiming to bring even more advancements to surgical treatments.
Commitment to Ongoing Innovation
With significant funding aimed at advancing research and development in the field, Perimeter is poised for substantial growth. The potential FDA submission for the B-Series OCT scheduled for the near future indicates the company's dedication to maintaining a leading edge in medical imaging technology.
About Perimeter Medical Imaging AI, Inc.
Founded in Toronto, Canada, and Dallas, Texas, Perimeter Medical Imaging AI focuses on transforming cancer surgery through ultra-high-resolution imaging solutions. Their commitment to addressing high unmet medical needs in healthcare ensures that patients receive the most precise surgical interventions possible. With a dedicated support team and specialized technology, Perimeter aims to revolutionize cancer care delivery.
Frequently Asked Questions
What is the significance of the S-Series OCT technology?
The S-Series OCT technology significantly enhances the visualization of tissue margins during surgery, improving the potential for better patient outcomes.
How does the imaging technology affect surgical procedures?
By providing real-time, high-resolution images, the imaging technology helps surgeons make better decisions and reduces the likelihood of additional surgeries due to unclear margins.
Who is Dr. Amani Jambhekar?
Dr. Amani Jambhekar is a surgical breast oncologist at CHRISTUS St. Vincent, specializing in the treatment of breast cancer and melanoma.
What are the future plans for Perimeter Medical Imaging AI?
Perimeter is focused on continuous innovation, with the upcoming FDA submission for the B-Series OCT technology, designed to further enhance surgical imaging.
Where can patients find the S-Series OCT in use?
The S-Series OCT is currently in use at CHRISTUS St. Vincent, which is the first hospital to implement this advanced technology for breast cancer surgeries in its region.
About The Author
Contact Thomas Cooper privately here. Or send an email with ATTN: Thomas Cooper as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.